Posts

Synbiotic Health appoints Steve Prescott, MBA, as Senior Vice President, Business Development / Operations

Probiotics industry veteran to lead business strategy for company’s growing product portfolio

LINCOLN, Neb.  – June 10, 2021 – Synbiotic Health, a rapidly growing microbiome nutritional ingredients company, is pleased to announce that Steve Prescott, MBA, has taken on the role of Senior Vice President, Business Development. Prescott has extensive experience in the probiotics industry, having served as Global VP – Marketing and Operations and Global Business Director for leading probiotic producers.

At Synbiotic Health, Prescott will refine and implement the company’s strategy for business operations as he oversees product development, sales and marketing. Initially he will focus on bringing the company’s first commercially available ingredient, iVS-1 Ecologically-Advanced Probiotic™, to market.

“With his broad experience in the industry, Steve Prescott is a great addition to our growing team,” said Tim Brummels, Synbiotic Health CEO. “He’s very knowledgeable about business strategy and has previously brought new products to market. Importantly, since Synbiotic Health is a company that sets itself apart through scientific innovation, his solid technical background will serve him well in this role.”Prescott previously held positions with Probi and DuPont, and has been working in the probiotics industry for 9 years. He holds an MBA from Michigan State University and a MS in Organic Chemistry from Iowa State University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com

 

 

Zac Lewis, PhD, Joins Team at Synbiotic Health as Chief Scientific Officer

Will lead its ‘ecologically-advanced’ microbiome research & development efforts

FOR IMMEDIATE RELEASE

LINCOLN, Neb.  – March 16, 2021 – Synbiotic Health is pleased to announce the addition of Dr. Zac Lewis as its Chief Scientific Officer. Dr. Lewis’s responsibilities will be to lead the build out and implementation of Synbiotic Health’s research & development program. Dr. Lewis will also serve as a liaison between Synbiotic Health’s Scientific Founders and its commercial efforts. A primary focus will be to develop and introduce microbiome-based ingredients using Synbiotic Health’s unique ‘ecological’ approach that has resulted in novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

“We’re delighted to have Dr. Lewis join the team at Synbiotic Health,” said Tim Brummels, CEO/President with Synbiotic Health. “He brings the experience necessary to lead research efforts as well as commercialize our microbiome ingredients, and believes strongly in the value of using an ecological approach in product development.”

Dr. Lewis previously was an associate research fellow and microbiome subject matter expert with The Clorox Company working on the Renew Life brand, and has been involved in microbiome research for over 15 years. Dr. Lewis has authored or contributed to over 20 research publications and has spoken at a number of microbiome-related conferences. His key skill set includes probiotic and prebiotic product design, microbial ecology, bioinformatics, microbiology, and molecular biology. He holds a PhD in Microbiology from University of California, Davis and a BS in Microbiology from Brigham Young University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four noted microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com